Chemoembolization for Hepatocellular Carcinoma: Comprehensive Imaging and Survival Analysis in a 172-Patient Cohort

Authors:
  • MMMary F. Mulcahy
    Mary F. Mulcahy
  • LKLaura M. Kulik
    Laura M. Kulik
  • RRRobert K. Ryu
    Robert K. Ryu
  • TBTalia B. Baker
    Talia B. Baker
  • SISaad M. Ibrahim
    Saad M. Ibrahim
  • MAMichael I. Abecassis
    Michael I. Abecassis
  • FMFrank H. Miller
    Frank H. Miller
  • KSKent T. Sato
    Kent T. Sato
  • SSSeanthan Senthilnathan
    Seanthan Senthilnathan
  • SRScott A. Resnick
    Scott A. Resnick

Abstract
Chemoembolization is a safe and effective therapy in patients with hepatocellular carcinoma. PurposeTo determine comprehensive imaging and long-term survival outcome following chemoembolization for hepatocellular carcinoma (HCC).Materials and MethodsOne hundred seventy-two patients with HCC treated with chemoembolization were studied retrospectively in an institutional review board approved protocol; this study was HIPAA compliant. Baseline laboratory and imaging characteristics were obtained. Clinical and laboratory toxicities following treatment were assessed. Imaging characteristics following chemoembolization were evaluated to determine response rates (size and necrosis) and time to progression (TTP). Survival from the time of first chemoembolization treatment was calculated. Subanalyses were performed by stratifying the population according to Child-Pugh, United Network for Organ Sharing, and Barcelona Clinic for Liver Cancer (BCLC) staging systems.ResultsCirrhosis was present in 157 patients (91%); portal hypertension was present in 139 patients (81%). Eleven patients (6%) had metastases at...

This publication has 41 references indexed in Scilit: